• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Am J Obstet Gynecol MFM . Maternal and perinatal outcomes in high vs low risk-pregnancies affected by SARS-COV-2 infection (Phase-2): The WAPM (Wor

tetano

Editor, Senior Moderator
Am J Obstet Gynecol MFM


. 2021 Feb 20;100329.
doi: 10.1016/j.ajogmf.2021.100329. Online ahead of print.
Maternal and perinatal outcomes in high vs low risk-pregnancies affected by SARS-COV-2 infection (Phase-2): The WAPM (World Association of Perinatal Medicine) working group on COVID-19


Francesco D'Antonio[SUP] 1 [/SUP], Cihat Sen[SUP] 2 [/SUP], Daniele DI Mascio[SUP] 3 [/SUP], Alberto Galindo[SUP] 4 [/SUP], Cecilia Villalain[SUP] 4 [/SUP], Ignacio Herraiz[SUP] 4 [/SUP], Resul Arısoy[SUP] 5 [/SUP], Ali Ovayolu[SUP] 6 [/SUP], Hasan Eroğlu[SUP] 6 [/SUP], Manuel Guerra Canales[SUP] 7 [/SUP], Subhashini Ladella[SUP] 8 [/SUP], Liviu Cojocaru[SUP] 9 [/SUP], Ozhan Turan[SUP] 9 [/SUP], Sifa Turan[SUP] 9 [/SUP], Eran Hadar[SUP] 10 [/SUP], Noa A Brzezinski-Sinai[SUP] 10 [/SUP], Sarah Dollinger[SUP] 10 [/SUP], Ozlem Uyaniklar[SUP] 11 [/SUP], Sakine Rahimli Ocakouglu[SUP] 11 [/SUP], Zeliha Atak[SUP] 11 [/SUP], Tanja Premru-Srsen[SUP] 12 [/SUP], Lilijana Kornhauser-Cerar[SUP] 12 [/SUP], Mirjam Druškovič[SUP] 12 [/SUP], Liana Ples[SUP] 13 [/SUP], Reyhan G?nd?z[SUP] 14 [/SUP], Elif Ağa?ayak[SUP] 14 [/SUP], Javier Alfonso Schvartzman[SUP] 15 [/SUP], Mercedes Negri Malbran[SUP] 15 [/SUP], Marco Liberati[SUP] 16 [/SUP], Francesca Di Sebastiano[SUP] 16 [/SUP], Ludovica Oronzi[SUP] 16 [/SUP], Chiara Cerra[SUP] 16 [/SUP], Danilo Buca[SUP] 16 [/SUP], Angelo Cagnacci[SUP] 17 [/SUP], Arianna Ramone[SUP] 17 [/SUP], Fabio Barra[SUP] 17 [/SUP], Andrea Carosso[SUP] 18 [/SUP], Chiara Benedetto[SUP] 18 [/SUP], Stefano Cosma[SUP] 18 [/SUP], Axelle Pintiaux[SUP] 19 [/SUP], Caroline Daelemans[SUP] 19 [/SUP], Elena Costa[SUP] 19 [/SUP], Ayşeg?l ?zel[SUP] 20 [/SUP], Murat Muh?u[SUP] 20 [/SUP], Jes?s S Jimenez Lopez[SUP] 21 [/SUP], Clara Alvarado[SUP] 22 [/SUP], Anna Luengo Piqueras[SUP] 23 [/SUP], Dolores Esteban Oliva[SUP] 23 [/SUP], Giovanni Battista Luca Schera[SUP] 24 [/SUP], Nicola Volpe[SUP] 24 [/SUP], Tiziana Frusca[SUP] 24 [/SUP], Igor Samardjiski[SUP] 25 [/SUP], Slagjana Simeonova[SUP] 25 [/SUP], Irena Aleksioska Papestiev[SUP] 25 [/SUP], Javier Hojman[SUP] 26 [/SUP], Ilgin Turkcuoglu[SUP] 27 [/SUP], Antonella Cromi[SUP] 28 [/SUP], Antonio Simone Lagan?[SUP] 28 [/SUP], Fabio Ghezzi[SUP] 28 [/SUP], Angelo Sirico[SUP] 29 [/SUP], Alessandra Familiari[SUP] 29 [/SUP], Giovanni Scambia[SUP] 29 [/SUP], Zulfiya Khodjaeva Gennady T Sukhikh[SUP] 30 [/SUP], Ksenia A Gorina[SUP] 30 [/SUP], Renato Augusto Moreira de Sa[SUP] 31 [/SUP], Mariana Vaz[SUP] 31 [/SUP], Otto Henrique May Feuerschuette[SUP] 32 [/SUP], Anna Nunzia Della Gatta[SUP] 33 [/SUP], Aly Youssef[SUP] 33 [/SUP], Gaetana Di Donna[SUP] 33 [/SUP], Alicia Martinez-Varea[SUP] 34 [/SUP], Gabriela Loscalzo[SUP] 34 [/SUP], Jos? Morales Rosell?[SUP] 34 [/SUP], Vedran Stefanovic[SUP] 35 [/SUP], Irmeli Nupponen[SUP] 35 [/SUP], Kaisa Nelskyl?[SUP] 35 [/SUP], Rodrigo Ayala[SUP] 36 [/SUP], Rebeca Garrote Molpeceres[SUP] 37 [/SUP], Asunci?n Pino V?zquez[SUP] 37 [/SUP], Fabrizio Sandri[SUP] 38 [/SUP], Ilaria Cataneo[SUP] 38 [/SUP], Marinella Lenzi[SUP] 38 [/SUP], Esra Tustas Haberal[SUP] 39 [/SUP], Erasmo Huertas[SUP] 40 [/SUP], Amadeo Sanchez[SUP] 40 [/SUP], Pedro Arango[SUP] 40 [/SUP], Amanda Bermejo[SUP] 41 [/SUP], Mar?a Monica Gonzalez Alcantara[SUP] 42 [/SUP], G?khan G?yn?mer[SUP] 43 [/SUP], Erhan Okuyan[SUP] 44 [/SUP], Ciuhodaru Madalina[SUP] 45 [/SUP], Ana Concheiro Guisan[SUP] 46 [/SUP], Alejandra Mart?nez Schulte[SUP] 47 [/SUP], Valentina Esposito[SUP] 48 [/SUP], Valentina De Robertis[SUP] 49 [/SUP], Snezana Zdjelar[SUP] 50 [/SUP], Milan Lackovic[SUP] 50 [/SUP], Sladjana Mihajlovic[SUP] 50 [/SUP], Nelly Jekova[SUP] 51 [/SUP], Gabriele Saccone[SUP] 52 [/SUP], Mehmet Musa Aslan[SUP] 53 [/SUP], Maria Carmela Di Dedda[SUP] 54 [/SUP], Maisuri Chalid[SUP] 55 [/SUP], Jose Enrique Moros Canache[SUP] 56 [/SUP], George Daskalakis[SUP] 57 [/SUP], Panos Antsaklis[SUP] 57 [/SUP], Enrique Criado Vega[SUP] 58 [/SUP], Elisa Cueto[SUP] 59 [/SUP], Chiara Taccaliti[SUP] 60 [/SUP], Alicia Yeliz Aykanat[SUP] 61 [/SUP], Şerife ?zlem Gen?[SUP] 62 [/SUP], Bernd Froessler[SUP] 63 [/SUP], Petya Angelova Radulova[SUP] 64 [/SUP], Danila Morano[SUP] 65 [/SUP], Beatrice Bianchi[SUP] 65 [/SUP], Maria Giulia Lombana Marino[SUP] 65 [/SUP], Gabriella Meccariello[SUP] 66 [/SUP], Bindu Rohatgi[SUP] 67 [/SUP], Antonio Schiattarella[SUP] 68 [/SUP], Maddalena Morlando[SUP] 68 [/SUP], Nicola Colacurci[SUP] 68 [/SUP], Andrea Villasco[SUP] 69 [/SUP], Nicoletta Biglia[SUP] 69 [/SUP], Ana Luiza Santos Marques[SUP] 70 [/SUP], Alessandra Gatti[SUP] 71 [/SUP], Daniela Luvero[SUP] 71 [/SUP], Roberto Angioli[SUP] 71 [/SUP], Alejandro Pittaro[SUP] 72 [/SUP], Albert Lila[SUP] 73 [/SUP], Blanka Zlatohl?vkov?[SUP] 74 [/SUP]



Affiliations

Abstract

Objectives: To evaluate maternal and perinatal outcomes in high compared to low-risk pregnancies complicated by SARS-COV-2 infection.
Methods: This was a multinational retrospective cohort study including women with laboratory-confirmed SARS-COV-2 from 76 centers from 25 different countries in Europe, United States, South America, Asia and Australia from 04 April 2020 till 28 October 2020. The primary outcome was a composite measure of maternal mortality and morbidity including admission to intensive care unit (ICU), use of mechanical ventilation, or death. Secondary outcome was a composite measure of adverse perinatal outcome, including miscarriage, fetal loss, neonatal (NND) and perinatal (PND) death, and admission to neonatal intensive care unit. All these outcomes were assessed in high-risk compared to low-risk pregnancies. Pregnancies were considered as high risk in case of either pre-existing chronic medical conditions pre-existing pregnancy or obstetric disorders occurring in pregnancy. Fisher-test and logistic regression analysis were used to analyze the data.
Results: 887 singleton pregnancies tested positive to SARS-COV-2 at RT-PCR nasal and pharyngeal swab were included in the study. The risk of composite adverse maternal outcome was higher in high compared to low risk-pregnancies with an OR of 1.52 (95% CU 1.03-2.24; p= 0.035). Likewise, women carrying a high risk-pregnancies were also at higher risk of hospital admission (OR: 1.48, 95% CI 1.07-2.04; p= 0.002), presence of severe respiratory symptoms (OR: 2.13, 95% CI .41-3.21; p= 0.001), admission to ICU (OR: 2.63, 95% CI 1.42-4.88) and invasive mechanical ventilation (OR: 2.65, 95% CI 1.19- 5.94; p= .002). When exploring perinatal outcomes, high-risk pregnancies were also at high risk of adverse perinatal outcome with an OR 0f 1.78 (95% CI .15-2.72; p= 0.009). However, such association was mainly due to the higher incidence of miscarriage in high risk compared to low risk pregnancies (5.3% vs 1.6%, p= 0.008), while there was no difference as regard as the other explored outcomes between the two study groups. At logistic regression analysis, maternal age (OR: 1.12, 95% CI 1.02-1.22, p= 0.023) and the presence of a high-risk pregnancies (OR: 4.21, 95% CI 3.90-5.11, p<0.001) were independently associated with adverse maternal outcome.
Conclusions: High-risk pregnancies complicated by SARS-COV-2 infection are at higher risk of adverse maternal outcome compared to low-risk gestations.

Keywords: COVID19; Coronavirus; SARS-COV-2; infection; pregnancy.
 
Back
Top Bottom